Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Hansa Biopharma AB

Closing information (x1000 NOK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 135,841 More Arrow 146,167 Less Arrow 33,039
Financial expenses 106,895 Less Arrow 46,008 Less Arrow 1,189
Earnings before taxes -841,639 More Arrow -576,987 More Arrow -534,549
EBITDA -788,818 More Arrow -556,753 More Arrow -533,425
Total assets 1,031,308 More Arrow 1,596,139 Less Arrow 987,713
Current assets 866,295 More Arrow 1,517,910 Less Arrow 918,993
Current liabilities 325,171 Less Arrow 250,396 Less Arrow 166,977
Equity capital -170,064 More Arrow 570,301 More Arrow 738,802
- share capital 55,751 Less Arrow 52,057 Less Arrow 45,187
Employees (average) 159 Less Arrow 144 Less Arrow 116

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency -16.5% More Arrow 35.7% More Arrow 74.8%
Turnover per employee 854 More Arrow 1,015 Less Arrow 285
Profit as a percentage of turnover -619.6% More Arrow -394.7% Less Arrow -1617.9%
Return on assets (ROA) -71.2% More Arrow -33.3% Less Arrow -54.0%
Current ratio 266.4% More Arrow 606.2% Less Arrow 550.4%
Return on equity (ROE) 494.9% Less Arrow -101.2% More Arrow -72.4%
Change turnover -20,697 More Arrow 114,122 Less Arrow 27,092
Change turnover % -13% More Arrow 356% More Arrow 456%
Chg. No. of employees 15 More Arrow 28 More Arrow 34
Chg. No. of employees % 10% More Arrow 24% More Arrow 41%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.